发明申请
US20120270847A1 NOVEL CARBAMATE AMINO ACID AND PEPTIDE PRODRUGS OF OPIATES AND USES THEREOF
审中-公开
新型卡氨酸氨基酸和肽类的优点及其用途
- 专利标题: NOVEL CARBAMATE AMINO ACID AND PEPTIDE PRODRUGS OF OPIATES AND USES THEREOF
- 专利标题(中): 新型卡氨酸氨基酸和肽类的优点及其用途
-
申请号: US13383831申请日: 2010-07-16
-
公开(公告)号: US20120270847A1公开(公告)日: 2012-10-25
- 发明人: Richard Franklin , Bernard T. Golding , Robert G. Tyson
- 申请人: Richard Franklin , Bernard T. Golding , Robert G. Tyson
- 申请人地址: US KY FLORENCE
- 专利权人: SHIRE LLC
- 当前专利权人: SHIRE LLC
- 当前专利权人地址: US KY FLORENCE
- 国际申请: PCT/IB2010/001747 WO 20100716
- 主分类号: A61K31/55
- IPC分类号: A61K31/55 ; C07D223/04 ; A61K31/625 ; C07D403/12 ; C07D411/12 ; A61P25/04 ; C07D405/12
摘要:
Carbamate linked prodrugs of meptazinol and other opioid analgesics are provided. The prodrug moiety may comprise a single amino acid or short peptide. Additionally, the present invention relates to methods for reducing gastrointestinal side effects in a subject, the gastrointestinal side effects being associated with the administration of an opioid analgesic. The methods comprise orally administering an opioid prodrug or pharmaceutically acceptable salt thereof to a subject, wherein the opioid pro-drug is comprised of an opioid analgesic covalently bonded through a carbamate linkage to a prodrug moiety, and wherein upon oral administration, the prodrug or pharmaceutically acceptable salt minimizes at least one gastrointestinal side effect associated with oral administration of the opioid analgesic alone. Compositions for use with the method are also provided.
信息查询